Literature DB >> 35143040

Cancer statistics for African American/Black People 2022.

Angela N Giaquinto1, Kimberly D Miller1, Katherine Y Tossas2, Robert A Winn2, Ahmedin Jemal1, Rebecca L Siegel1.   

Abstract

African American/Black individuals have a disproportionate cancer burden, including the highest mortality and the lowest survival of any racial/ethnic group for most cancers. Every 3 years, the American Cancer Society estimates the number of new cancer cases and deaths for Black people in the United States and compiles the most recent data on cancer incidence (herein through 2018), mortality (through 2019), survival, screening, and risk factors using population-based data from the National Cancer Institute and the Centers for Disease Control and Prevention. In 2022, there will be approximately 224,080 new cancer cases and 73,680 cancer deaths among Black people in the United States. During the most recent 5-year period, Black men had a 6% higher incidence rate but 19% higher mortality than White men overall, including an approximately 2-fold higher risk of death from myeloma, stomach cancer, and prostate cancer. The overall cancer mortality disparity is narrowing between Black and White men because of a steeper drop in Black men for lung and prostate cancers. However, the decline in prostate cancer mortality in Black men slowed from 5% annually during 2010 through 2014 to 1.3% during 2015 through 2019, likely reflecting the 5% annual increase in advanced-stage diagnoses since 2012. Black women have an 8% lower incidence rate than White women but a 12% higher mortality; further, mortality rates are 2-fold higher for endometrial cancer and 41% higher for breast cancer despite similar or lower incidence rates. The wide breast cancer disparity reflects both later stage diagnosis (57% localized stage vs 67% in White women) and lower 5-year survival overall (82% vs 92%, respectively) and for every stage of disease (eg, 20% vs 30%, respectively, for distant stage). Breast cancer surpassed lung cancer as the leading cause of cancer death among Black women in 2019. Targeted interventions are needed to reduce stark cancer inequalities in the Black community.
© 2022 The Authors. CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society.

Entities:  

Keywords:  African Americans; Black people; cancer statistics; incidence; mortality

Mesh:

Year:  2022        PMID: 35143040     DOI: 10.3322/caac.21718

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   286.130


  14 in total

1.  Evaluation of antitumor effects of VEGFR-2 inhibitor F16 in a colorectal xenograft model.

Authors:  Khalid Alhazzani; Thiagarajan Venkatesan; Umamaheswari Natarajan; Mohammad Algahtani; Ali Alaseem; Saad Alobid; Appu Rathinavelu
Journal:  Biotechnol Lett       Date:  2022-04-30       Impact factor: 2.461

2.  Associations of lung cancer risk with biomarkers of Helicobacter pylori infection.

Authors:  Hyung-Suk Yoon; Xiao-Ou Shu; Hui Cai; Wei Zheng; Jie Wu; Wanqing Wen; Regina Courtney; Chris Shidal; Tim Waterboer; William J Blot; Qiuyin Cai
Journal:  Carcinogenesis       Date:  2022-06-27       Impact factor: 4.741

3.  Geriatric Nutritional Risk Index and Survival of Patients With Colorectal Cancer: A Meta-Analysis.

Authors:  Haiming Zhao; Li Xu; Peng Tang; Rui Guo
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

4.  Associations of Pre-Diagnostic Serum Levels of Total Bilirubin and Albumin With Lung Cancer Risk: Results From the Southern Community Cohort Study.

Authors:  Hyung-Suk Yoon; Xiao-Ou Shu; Chris Shidal; Jie Wu; William J Blot; Wei Zheng; Qiuyin Cai
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

5.  Estimating Overdiagnosis of Melanoma Using Trends Among Black and White Patients in the US.

Authors:  Adewole S Adamson; Elizabeth A Suarez; H Gilbert Welch
Journal:  JAMA Dermatol       Date:  2022-04-01       Impact factor: 11.816

6.  Banning Menthol Cigarettes: The Time Has Come.

Authors:  Andrew L Pipe
Journal:  J Natl Cancer Inst       Date:  2022-07-11       Impact factor: 11.816

7.  Enrollment of Black Participants in Pivotal Clinical Trials Supporting US Food and Drug Administration Approval of Chimeric Antigen Receptor-T Cell Therapy for Hematological Malignant Neoplasms.

Authors:  Samer Al Hadidi; Carolina Schinke; Sharmilan Thanendrarajan; Maurizio Zangari; Frits van Rhee
Journal:  JAMA Netw Open       Date:  2022-04-01

8.  Association of Race With Receipt of Proton Beam Therapy for Patients With Newly Diagnosed Cancer in the US, 2004-2018.

Authors:  Leticia M Nogueira; Helmneh M Sineshaw; Ahmedin Jemal; Craig E Pollack; Jason A Efstathiou; K Robin Yabroff
Journal:  JAMA Netw Open       Date:  2022-04-01

9.  Commencing colorectal cancer screening at age 45 years in U.S. racial groups.

Authors:  John M Carethers
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

10.  Comparison of Long-Term Survival Between cT1N0 Stage Esophageal Cancer Patients Receiving Endoscopic Dissection and Esophagectomy: A Meta-Analysis.

Authors:  Wei Lu; Peng Li; Wu Wen; Yi Jian
Journal:  Front Surg       Date:  2022-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.